Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
WST West Pharmaceutical Services Inc
- Stocks
- Healthcare
- NYSE: WST
Price (delayed)
$216.64
Market cap
$15.56B
P/E Ratio
33.74
Dividend/share
$0.83
EPS
$6.42
Enterprise value
$15.46B
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe,
Highlights
The stock's price to earnings (P/E) is 29% less than its 5-year quarterly average of 47.3 and 22% less than its last 4 quarters average of 43.5
West Pharmaceutical Services's quick ratio has decreased by 4.3% from the previous quarter but it has increased by 3.4% YoY
The net income has contracted by 18% YoY and by 5% from the previous quarter
WST's EPS is down by 16% year-on-year and by 4.9% since the previous quarter
Key stats
What are the main financial stats of WST
Market
Valuations
Earnings
Shares outstanding
71.85M
Market cap
$15.56B
Enterprise value
$15.46B
Price to earnings (P/E)
33.74
Price to book (P/B)
5.84
Price to sales (P/S)
5.42
EV/EBIT
26.47
EV/EBITDA
20.78
EV/Sales
5.34
Revenue
$2.9B
Gross profit
$1B
Operating income
$554.1M
Net income
$467.2M
EBIT
$584.2M
EBITDA
$744M
Free cash flow
$306.9M
Per share
Balance sheet
Liquidity
EPS
$6.42
EPS diluted
$6.37
Free cash flow per share
$4.23
Book value per share
$37.11
Revenue per share
$39.94
TBVPS
$48.29
Total assets
$3.62B
Total liabilities
$935.1M
Debt
$303.2M
Equity
$2.68B
Working capital
$930.8M
Debt to equity
0.11
Current ratio
2.77
Quick ratio
1.8
Net debt/EBITDA
-0.14
Margins
Efficiency
Dividend
EBITDA margin
25.7%
Gross margin
34.5%
Net margin
16.1%
Operating margin
19.1%
Return on assets
13%
Return on equity
17.5%
Return on invested capital
21%
Return on capital employed
18.9%
Return on sales
20.2%
Dividend yield
0.38%
DPS
$0.83
Payout ratio
12.9%
WST stock price
How has the West Pharmaceutical Services stock price performed over time
Intraday
2.83%
1 week
1.68%
1 month
3.59%
1 year
-38.82%
YTD
-33.86%
QTD
-3.23%
Financial performance
How have West Pharmaceutical Services's revenue and profit performed over time
Revenue
$2.9B
Gross profit
$1B
Operating income
$554.1M
Net income
$467.2M
Gross margin
34.5%
Net margin
16.1%
The net income has contracted by 18% YoY and by 5% from the previous quarter
WST's net margin is down by 17% year-on-year and by 5% since the previous quarter
WST's operating income is down by 14% YoY and by 2.8% from the previous quarter
The operating margin has declined by 13% year-on-year and by 3% since the previous quarter
Price vs fundamentals
How does WST's price correlate with its fundamentals
Growth
What is West Pharmaceutical Services's growth rate over time
Valuation
What is West Pharmaceutical Services stock price valuation
P/E
33.74
P/B
5.84
P/S
5.42
EV/EBIT
26.47
EV/EBITDA
20.78
EV/Sales
5.34
The stock's price to earnings (P/E) is 29% less than its 5-year quarterly average of 47.3 and 22% less than its last 4 quarters average of 43.5
WST's EPS is down by 16% year-on-year and by 4.9% since the previous quarter
The price to book (P/B) is 43% lower than the 5-year quarterly average of 10.2 and 27% lower than the last 4 quarters average of 8.0
The P/S is 40% below the 5-year quarterly average of 9.0 and 28% below the last 4 quarters average of 7.5
Efficiency
How efficient is West Pharmaceutical Services business performance
WST's return on invested capital is down by 24% year-on-year and by 6% since the previous quarter
The company's return on assets fell by 15% YoY and by 5% QoQ
WST's return on sales is down by 14% year-on-year and by 2.9% since the previous quarter
West Pharmaceutical Services's ROE has decreased by 14% YoY and by 4.9% from the previous quarter
Dividends
What is WST's dividend history
DPS
$0.83
Dividend yield
0.38%
Payout ratio
12.9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did West Pharmaceutical Services financials performed over time
West Pharmaceutical Services's current ratio has increased by 6% YoY
West Pharmaceutical Services's quick ratio has decreased by 4.3% from the previous quarter but it has increased by 3.4% YoY
WST's debt is 89% smaller than its equity
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.